NO308123B1 - Sprayanordning og aerosolblanding for utposjonering av en oppløsning av nikotin eller et farmasøytisk akseptabelt salt derav - Google Patents

Sprayanordning og aerosolblanding for utposjonering av en oppløsning av nikotin eller et farmasøytisk akseptabelt salt derav

Info

Publication number
NO308123B1
NO308123B1 NO942502A NO942502A NO308123B1 NO 308123 B1 NO308123 B1 NO 308123B1 NO 942502 A NO942502 A NO 942502A NO 942502 A NO942502 A NO 942502A NO 308123 B1 NO308123 B1 NO 308123B1
Authority
NO
Norway
Prior art keywords
pharmaceutically acceptable
nicotine
pct
acceptable salt
solution
Prior art date
Application number
NO942502A
Other languages
English (en)
Norwegian (no)
Other versions
NO942502D0 (no
NO942502L (no
Inventor
Richard L Jones
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of NO942502D0 publication Critical patent/NO942502D0/no
Publication of NO942502L publication Critical patent/NO942502L/no
Publication of NO308123B1 publication Critical patent/NO308123B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Confectionery (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO942502A 1992-01-03 1994-07-01 Sprayanordning og aerosolblanding for utposjonering av en oppløsning av nikotin eller et farmasøytisk akseptabelt salt derav NO308123B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929200047A GB9200047D0 (en) 1992-01-03 1992-01-03 Nicotine-containing nasal spray
PCT/CA1993/000003 WO1993012764A1 (en) 1992-01-03 1993-01-04 Composition to help stop smoking

Publications (3)

Publication Number Publication Date
NO942502D0 NO942502D0 (no) 1994-07-01
NO942502L NO942502L (no) 1994-09-02
NO308123B1 true NO308123B1 (no) 2000-07-31

Family

ID=10708064

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942502A NO308123B1 (no) 1992-01-03 1994-07-01 Sprayanordning og aerosolblanding for utposjonering av en oppløsning av nikotin eller et farmasøytisk akseptabelt salt derav

Country Status (21)

Country Link
US (1) US5656255A (de)
EP (1) EP0619729B1 (de)
JP (1) JP3830158B2 (de)
KR (2) KR950700055A (de)
AT (1) ATE182070T1 (de)
AU (1) AU664415B2 (de)
CA (1) CA2127253C (de)
CZ (1) CZ294555B6 (de)
DE (1) DE69325643T2 (de)
DK (1) DK0619729T3 (de)
ES (1) ES2135460T3 (de)
FI (1) FI111049B (de)
GB (1) GB9200047D0 (de)
GR (1) GR3031075T3 (de)
HU (1) HUT73247A (de)
NO (1) NO308123B1 (de)
NZ (1) NZ246533A (de)
RU (1) RU2118897C1 (de)
SK (1) SK282336B6 (de)
UA (1) UA37201C2 (de)
WO (1) WO1993012764A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
AUPM835394A0 (en) * 1994-09-23 1994-10-13 King, Michael G. Dr. Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
JPH11507810A (ja) * 1995-06-05 1999-07-13 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Ｇタンパク質副甲状腺ホルモンレセプターｈｌｔｄｇ７４
CA2231968A1 (en) * 1998-03-11 1999-09-11 Smoke-Stop, A Partnership Consisting Of Art Slutsky Method of producing a nicotine medicament
GB9806937D0 (en) 1998-03-31 1998-05-27 Procter & Gamble A spray device
CA2359813C (en) 2000-10-24 2008-04-22 Richard L. Jones Nicotine mucosal spray
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
SE521512C2 (sv) * 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
EP1304048B1 (de) * 2001-10-22 2004-09-22 Ivo Pera Zusammensetzung zur Reduzierung oder Entwöhnung von Nikotinabhängigkeit
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20030159702A1 (en) * 2002-01-21 2003-08-28 Lindell Katarina E.A. Formulation and use manufacture thereof
US20030171408A1 (en) * 2002-03-11 2003-09-11 Caplan Jay L. Therapeutic method of delivering a medicament to avoid irritating effects on membranes of user
US7767698B2 (en) 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
SE0201669D0 (sv) * 2002-06-03 2002-06-03 Pharmacia Ab New formulation and use thereof
US20040002520A1 (en) * 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
DK1578422T3 (da) 2002-12-20 2007-07-02 Niconovum Ab Fysisk og kemisk stabilt nikotin-indeholdende partikelholdigt materiale
US20050079166A1 (en) 2003-05-21 2005-04-14 Alexza Molecular Delivery Corporation Self-contained heating unit and drug-supply unit employing same
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
AU2005284908B2 (en) 2004-09-13 2011-12-08 Morningside Venture Investments Limited Biosynchronous transdermal drug delivery
US7766018B2 (en) * 2004-09-30 2010-08-03 Smoke-Break, Inc. Device and composition for reducing the incidence of tobacco smoking
US8322350B2 (en) 2004-12-30 2012-12-04 Philip Morris Usa Inc. Aerosol generator
US8323683B2 (en) 2005-05-18 2012-12-04 Mcneil-Ppc, Inc. Flavoring of drug-containing chewing gums
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
EP2121088B1 (de) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Erhitzungseinheit zur verwendung in einer arzneimittelabgabevorrichtung
AU2008232453B8 (en) * 2007-04-02 2011-07-21 Parkinson's Institute Methods and compositions for reduction of side effects of therapeutic treatments
ES2552014T3 (es) * 2007-11-30 2015-11-25 Japan Tobacco Inc. Disolución de generación de aerosol para su uso en un inhalador de aerosol
EP2233134A1 (de) 2009-03-27 2010-09-29 McNeil AB Mehrteilige intraorale Darreichungsform mit organoleptischen Eigenschaften
WO2011087393A1 (ru) * 2010-01-18 2011-07-21 Общество С Ограниченной Ответственностью "Вегавольт" Композиция растительного происхождения, предназначенная для вдыхания дыма, образующегося при ее сжигании
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
JP2018511127A (ja) 2015-03-12 2018-04-19 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 渇望入力及び支援システム
US10532046B2 (en) 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
AU2017228051B2 (en) * 2016-02-29 2022-06-23 Nicogen Ltd. Nicotine formulation and aerosols
JP2020503950A (ja) 2017-01-06 2020-02-06 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 経皮薬剤送達の装置及び方法
SE541358C2 (en) 2017-05-30 2019-08-13 Enorama Pharma Ab Nicotine-containing chewing gum compositions
EP3801732A4 (de) 2018-05-29 2022-04-27 Morningside Venture Investments Limited Verfahren und systeme zur wirkstofffreisetzung
BR112020025604A2 (pt) 2018-06-15 2021-03-23 R.J. Reynolds Tobacco Company purificação de nicotina
CZ309558B6 (cs) * 2021-05-25 2023-04-12 Consumer Brands International s.r.o. Náplň nikotinového prostředku, zejména nikotinového sáčku a způsob jeho výroby

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2030862A (en) * 1978-04-10 1980-04-16 Smith A A composition for treating drug addiction such as smoking nicotine-containing products
DE3241437A1 (de) * 1982-11-10 1984-05-10 Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern
GB2133691B (en) * 1983-01-21 1986-05-21 Leo Ab Smoking substitutes for nasal administration
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
US4953572A (en) * 1985-04-25 1990-09-04 Rose Jed E Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4920989A (en) * 1985-04-25 1990-05-01 Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4715387A (en) * 1985-08-23 1987-12-29 The Regents Of The Univ. Of California Aerosol for use in the reduction of tobacco smoking
SE8601351D0 (sv) * 1986-03-24 1986-03-24 Nilsson Sven Erik Styrd administration av fysiologiskt aktiva emnen
GB8614805D0 (en) * 1986-06-18 1986-07-23 British American Tobacco Co Aerosol device

Also Published As

Publication number Publication date
UA37201C2 (uk) 2001-05-15
SK79694A3 (en) 1995-06-07
US5656255A (en) 1997-08-12
NZ246533A (en) 1996-04-26
ES2135460T3 (es) 1999-11-01
JPH07504164A (ja) 1995-05-11
DK0619729T3 (da) 2000-04-17
DE69325643T2 (de) 2000-02-10
CZ160894A3 (en) 1995-09-13
FI943173A0 (fi) 1994-07-01
KR950700055A (ko) 1995-01-16
DE69325643D1 (de) 1999-08-19
AU3340393A (en) 1993-07-28
HUT73247A (en) 1996-07-29
JP3830158B2 (ja) 2006-10-04
CA2127253C (en) 1999-09-21
WO1993012764A1 (en) 1993-07-08
HU9402003D0 (en) 1994-09-28
SK282336B6 (sk) 2002-01-07
KR100317426B1 (de) 2001-11-30
NO942502D0 (no) 1994-07-01
AU664415B2 (en) 1995-11-16
GR3031075T3 (en) 1999-12-31
CA2127253A1 (en) 1993-07-08
NO942502L (no) 1994-09-02
ATE182070T1 (de) 1999-07-15
CZ294555B6 (cs) 2005-02-16
FI111049B (fi) 2003-05-30
EP0619729B1 (de) 1999-07-14
GB9200047D0 (en) 1992-02-26
FI943173A (fi) 1994-09-01
RU94040387A (ru) 1996-10-20
RU2118897C1 (ru) 1998-09-20
EP0619729A1 (de) 1994-10-19

Similar Documents

Publication Publication Date Title
NO308123B1 (no) Sprayanordning og aerosolblanding for utposjonering av en oppløsning av nikotin eller et farmasøytisk akseptabelt salt derav
US5810018A (en) Method, composition and apparatus for reducing the incidence of cigarette smoking
US4635651A (en) Process for the inclusion of a solid particulate component into aerosol formulations of inhalable nicotine
US5783207A (en) Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
CA2359813A1 (en) Nicotine mucosal spray
JPH072654A (ja) 吸入によるタウリン投与装置
FI944123A0 (fi) Farmaseuttiset inhalaatiokoostumukset
WO1996000071A1 (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a liquid nasal composition containing nicotine and caffeine or xanthine
EP0003064A2 (de) Verfahren zum Einführen von Vitamin A-Analogen in die Atemwege eines Zigarettenrauchers
EP0266443B1 (de) Verfahren zur Beimischung einer festen teilchenförmigen Komponente in Aerosolpräparate zur Inhalation des Nikotins
WO1996000069A1 (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a solid or semi-solid composition containing nicotine and caffeine or xanthine, especially for nasal administration
PL297882A1 (en) Agent facilitating to lose the habit of cigarette smoking